36 DRUGS
10 COMPANIESDRUGS
2014 YEAR IN REVIEW
FDADRUG APPROVALS
Novel Drugs Approved in 2014
APPROVED
Type 2 Diabetes
Source: FDA.GOV
FARXIGA 1
Non24Hour SleepWake Disorder
Source: FDA.GOV
HETLIOZ 2
Morquio A Syndrome
Source: FDA.GOV
VIMIZIM 3
Neurogenic Orthostatic Hypotension(NOH)
Source: FDA.GOV
NORTHERA 4
Complications of Leptin Deficiency
Source: FDA.GOV
MYALEPT 5
Positron Emission Tomography (PET)Imaging of the Brain
Source: FDA.GOV
NEURACEQ 6
Leishmaniasis
Source: FDA.GOV
IMPAVIDO 7
Moderate to Severe Plaque Psoriasis
Source: FDA.GOV
OTEZLA 8
Type 2 Diabetes
Source: FDA.GOV
TANZEUM 9
Advanced Stomach Cancer orGastroesophageal JunctionAdenocarcinoma
Source: FDA.GOV
CYRAMZA 10
Multicentric Castleman’s Disease (MCD)
Source: FDA.GOV
SYLVANT 11
Anaplastic Lymphoma KinasePositive(ALK+) Metastatic NonSmall Cell LungCancer (NSCLC)
Source: FDA.GOV
ZYKADIA 12
Reduce Risk of Heart Attacks and Stroke inHighRisk Patients
Source: FDA.GOV
ZONTIVITY 13
Severe Ulcerative Colitis and AdultPatients with Moderate to Severe Crohn‘sDisease
Source: FDA.GOV
ENTYVIO 14
Acute Bacterial Skin and Skin StructureInfections
Source: FDA.GOV
DALVANCE 15
Toenail Fungus
Source: FDA.GOV
JUBLIA 16
Acute Bacterial Skin and Skin StructureInfections
Source: FDA.GOV
SIVEXTRO 17
Peripheral TCell Lymphoma (PTCL)
Source: FDA.GOV
BELEODAQ 18
Toenail Fungus
Source: FDA.GOV
KERYDIN 19
Chronic Lymphocytic Leukemia (CLL)Follicular Bcell nonHodgkin Lymphoma(FL)Small Lymphocytic Lymphoma (SLL)
Source: FDA.GOV
ZYDELIG 20
Chronic Obstructive Pulmonary Disease(COPD)
Source: FDA.GOV
STRIVERDIRESPIMAT
21
Type 2 Diabetes
Source: FDA.GOV
JARDIANCE 22
Type 2 Diabetes
Source: FDA.GOV
ORBACTIV 23
Insomnia
Source: FDA.GOV
BELSOMRA 24
Relapsing Forms of Multiple Sclerosis (MS)
Source: FDA.GOV
PLEGRIDY 25
Gaucher Disease Type 1
Source: FDA.GOV
CERDELGA 26
Melanoma
Source: FDA.GOV
KEYTRUDA 27
OpioidInduced Constipation (OIC) in AdultPatients with Chronic Non‑Cancer Pain
Source: FDA.GOV
MOVANTIK 28
Type 2 Diabetes
Source: FDA.GOV
TRULICITY 29
Type 2 Diabetes
Source: FDA.GOV
LUMASON 30
Nausea and Vomiting in PatientsUndergoing Cancer Chemotherapy
Source: FDA.GOV
AKYNZEO 31
Chronic Hepatitis C
Source: FDA.GOV
HARVONI 32
Idiopathic Pulmonary Fibrosis (IPF)
Source: FDA.GOV
ESBRIET 33
Idiopathic Pulmonary Fibrosis (IPF)
Source: FDA.GOV
OFEV 34
Acute Lymphoblastic Leukemia
Source: FDA.GOV
BLINCYTO 35
Otitis Externa (Swimmer's Ear)
Source: FDA.GOV
XTORO 36
Advanced Ovarian Cancer
Source: FDA.GOV
LYNPARZA 37
Chronic Genotype 1 Hepatitis C
Source: FDA.GOV
VIEKIRA PAK 38
COMPLICATED URINARY TRACT ANDCOMPLICATED INTRAABDOMINALINFECTIONS
Source: FDA.GOV
ZERBAXA 39
Acute Uncomplicated Influenza
Source: FDA.GOV
RAPIVAB 40
Advanced Melanoma
Source: FDA.GOV
OPDIVO 41
Chronic Weight Management
Source: FDA.GOV
SAXENDA 42
Chronic Lymphocytic Leukemia
Source: FDA.GOV
IMBRUVICA 43
Type 2 Diabetes
Source: FDA.GOV
INVOKAMET 44
Inflammatory Lesions, Bumps andPimples, of Rosacea
Source: FDA.GOV
SOOLANTRA 45
36 DRUGS
10 COMPANIES
DRUGS
CREATED BY: